These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1824894)
1. A new approach for analysis of the mixed lymphocyte reaction that is predictive for human renal allograft rejection. Muluk SC; Clerici M; Via CS; Wier MR; Kimmel PL; Shearer GM Transplant Proc; 1991 Feb; 23(1 Pt 2):1274-6. PubMed ID: 1824894 [No Abstract] [Full Text] [Related]
2. Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporin A. Clerici M; Shearer GM J Immunol; 1990 Apr; 144(7):2480-5. PubMed ID: 1969447 [TBL] [Abstract][Full Text] [Related]
3. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590 [TBL] [Abstract][Full Text] [Related]
4. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. van der Mast BJ; van Besouw NM; de Kuiper P; Vaessen LM; Gregoor PJ; IJzermans JN; van Gelder T; Claas FH; Weimar W Transplantation; 2001 Sep; 72(5):873-80. PubMed ID: 11571453 [TBL] [Abstract][Full Text] [Related]
5. The differential effect of alloantigen-blocking antibodies on unprimed and memory T helper cells. Shoker AS; Sheridan D; Kalra J Transplantation; 1995 Jul; 60(2):184-91. PubMed ID: 7624961 [TBL] [Abstract][Full Text] [Related]
6. Role of suppressor cells in cyclosporine-treated allograft recipients. Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD Transplant Proc; 1987 Feb; 19(1 Pt 2):1580-3. PubMed ID: 2950632 [No Abstract] [Full Text] [Related]
7. Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs. Schulick RD; Weir MB; Miller MW; Cohen DJ; Bermas BL; Shearer GM Transplantation; 1993 Sep; 56(3):590-6. PubMed ID: 8105569 [TBL] [Abstract][Full Text] [Related]
8. Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses. Bowes LG; Dumble LJ; Francis DM; Macdonald IM; Clunie GJ; Kincaid-Smith P Transplant Proc; 1990 Oct; 22(5):2139-40. PubMed ID: 2145672 [No Abstract] [Full Text] [Related]
9. Could analysis of helper T-cell precursor frequencies be used as a predictive parameter in renal transplantation? Mason PD; Warrens AN; Lechler RI Transplant Proc; 1995 Feb; 27(1):230-1. PubMed ID: 7878980 [No Abstract] [Full Text] [Related]
10. In vitro humoral responses of renal allograft recipients. Paczek L; Gaciong Z; Korczak-Kowalska G; Nowaczyk M; Górski A Transplant Proc; 1987 Feb; 19(1 Pt 2):1595. PubMed ID: 2978884 [No Abstract] [Full Text] [Related]
11. High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells. van der Leij J; van den Berg A; Albrecht EW; Blokzijl T; Roozendaal R; Gouw AS; de Jong KP; Stegeman CA; van Goor H; Chang NS; Poppema S Transplantation; 2003 Jun; 75(12):2076-82. PubMed ID: 12829915 [TBL] [Abstract][Full Text] [Related]
12. Amplification of in vitro tissue-associated (mixed lymphocyte kidney culture) immunity by allograft rejection. Miller J; Esquenazi V; Olson L; Roth D; Milgrom M; Fuller L Transplant Proc; 1987 Feb; 19(1 Pt 1):263-4. PubMed ID: 2978902 [No Abstract] [Full Text] [Related]
13. Analysis of the immunologic and pharmacodynamic effects of cyclosporine following renal transplantation. Keown PA; Coles R; Flechner I; Stawecki M; Stiller CR Transplant Proc; 1986 Dec; 18(6 Suppl 5):252-6. PubMed ID: 2947367 [No Abstract] [Full Text] [Related]
14. Construction of rat-mouse T hybridoma clones from rat kidney allograft-infiltrating cells with helper activity. Manca F; Haalttunen J; Ferry B; Jaakkola M; Gessaga M; Häyry P Transplant Proc; 1988 Apr; 20(2):159-60. PubMed ID: 2966465 [No Abstract] [Full Text] [Related]
15. Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype. Cranston D; Wood KJ; Carter NP; Morris PJ Transplant Proc; 1987 Feb; 19(1 Pt 1):505. PubMed ID: 2978918 [No Abstract] [Full Text] [Related]
16. Immunobiology of rejection and adaptation. Trivedi HL Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565 [TBL] [Abstract][Full Text] [Related]
17. CsA therapy affects the direct and indirect antigen-presentation pathway in cardiac allograft recipients. van Besouw NM; Vaessen LM; Balk AH; Mochtar B; Claas FH; Weimar W Transplant Proc; 1996 Dec; 28(6):3135-6. PubMed ID: 8962214 [No Abstract] [Full Text] [Related]
18. T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection. Braun MY; McCormack A; Webb G; Batchelor JR Transplant Proc; 1993 Feb; 25(1 Pt 2):863-4. PubMed ID: 8442250 [No Abstract] [Full Text] [Related]
19. Cytotoxic T lymphocytes, interleukin-2 and trophoblast involvement. Toder V; Blank M; Nebel L Contrib Gynecol Obstet; 1985; 14():23-35. PubMed ID: 2415297 [No Abstract] [Full Text] [Related]
20. In vitro effects of cyclosporine A on allogeneic and autologous lymphocyte stimulation: influence of HLA phenotypes. Scorza R; Vanoli M; Cigognini A; Fabio G; De Bernardi B; Zanussi C Transplant Proc; 1988 Apr; 20(2 Suppl 2):122-4. PubMed ID: 2966475 [No Abstract] [Full Text] [Related] [Next] [New Search]